{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/Johnson--Johnson-to-Acquire-Firefly-Bio-Inc--to-Expand-Oncology-Pipeline-with-Novel-Degrader-Antibody-Conjugate-Platform/default.aspx", "message": "News view counter 785847 successfully enlarged"}